Article ; Online: In perspective: CSL112 (apolipoprotein A-I) infusions and cardiovascular outcomes in patients with acute myocardial infarction: the ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II) trial.
European heart journal. Acute cardiovascular care
2024 Volume 13, Issue 4, Page(s) 362–364
MeSH term(s) | Humans ; Myocardial Infarction ; Apolipoprotein A-I/administration & dosage ; Infusions, Intravenous ; Treatment Outcome |
---|---|
Chemical Substances | Apolipoprotein A-I |
Language | English |
Publishing date | 2024-04-10 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 2663340-1 |
ISSN | 2048-8734 ; 2048-8726 |
ISSN (online) | 2048-8734 |
ISSN | 2048-8726 |
DOI | 10.1093/ehjacc/zuae046 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.